CavtheRx has a novel approach to inflammatory disease modification and a capital efficient development plan that will enable early de-risking.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free